Evofem Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for EVOFEM INC
EVOFEM INC has two approved drugs.
There are fifteen US patents protecting EVOFEM INC drugs.
Summary for Evofem Inc
| US Patents: | 15 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Evofem Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evofem Inc | SOLOSEC | secnidazole | GRANULE;ORAL | 209363-001 | Sep 15, 2017 | RX | Yes | Yes | 11,324,721 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Evofem Inc | SOLOSEC | secnidazole | GRANULE;ORAL | 209363-001 | Sep 15, 2017 | RX | Yes | Yes | 11,602,522 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Evofem Inc | SOLOSEC | secnidazole | GRANULE;ORAL | 209363-001 | Sep 15, 2017 | RX | Yes | Yes | 10,849,884 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Evofem Inc | PHEXX | citric acid; lactic acid; potassium bitartrate | GEL;VAGINAL | 208352-001 | May 22, 2020 | RX | Yes | Yes | 11,992,472 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Evofem Inc | PHEXX | citric acid; lactic acid; potassium bitartrate | GEL;VAGINAL | 208352-001 | May 22, 2020 | RX | Yes | Yes | 11,439,610 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Evofem Inc | PHEXX | citric acid; lactic acid; potassium bitartrate | GEL;VAGINAL | 208352-001 | May 22, 2020 | RX | Yes | Yes | 10,568,855 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Evofem Inc | SOLOSEC | secnidazole | GRANULE;ORAL | 209363-001 | Sep 15, 2017 | RX | Yes | Yes | 10,682,338 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Evofem Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Evofem Inc | PHEXX | citric acid; lactic acid; potassium bitartrate | GEL;VAGINAL | 208352-001 | May 22, 2020 | 6,706,276 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Evofem Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | 112016014506 | ⤷ Start Trial |
| Japan | 6352907 | ⤷ Start Trial |
| Japan | 2019056008 | ⤷ Start Trial |
| European Patent Office | 3308771 | ⤷ Start Trial |
| New Zealand | 703203 | ⤷ Start Trial |
| Japan | 2020019759 | ⤷ Start Trial |
| Japan | 2022070924 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
